Search hospitals > New York > Bronx
Montefiore Medical Center-Einstein Campus
Claim this profileBronx, New York 10461
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
Conducts research for Recurrence
240 reported clinical trials
52 medical researchers
Summary
Montefiore Medical Center-Einstein Campus is a medical facility located in Bronx, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Recurrence and other specialties. Montefiore Medical Center-Einstein Campus is involved with conducting 240 clinical trials across 667 conditions. There are 52 research doctors associated with this hospital, such as Sanjay Goel, Nitin Ohri, Benjamin A. Gartrell, and Della F. Makower.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
Top PIs
Sanjay GoelMontefiore Medical Center4 years of reported clinical research
Expert in Solid Tumors
Expert in Tumors
22 reported clinical trials
31 drugs studied
Nitin OhriMontefiore Medical Center-Einstein Campus7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
17 reported clinical trials
44 drugs studied
Benjamin A. GartrellMontefiore Medical Center-Einstein Campus3 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
14 reported clinical trials
31 drugs studied
Della F. MakowerMontefiore Medical Center-Einstein Campus6 years of reported clinical research
Studies Breast Cancer
Studies Cancer
12 reported clinical trials
23 drugs studied
Clinical Trials running at Montefiore Medical Center-Einstein Campus
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Tumors
Small Cell Lung Cancer
Anal Cancer
Prostate Cancer
Oropharyngeal Carcinoma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Montefiore Medical Center-Einstein Campus?
Montefiore Medical Center-Einstein Campus is a medical facility located in Bronx, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Tumors, Recurrence and other specialties. Montefiore Medical Center-Einstein Campus is involved with conducting 240 clinical trials across 667 conditions. There are 52 research doctors associated with this hospital, such as Sanjay Goel, Nitin Ohri, Benjamin A. Gartrell, and Della F. Makower.